FDA Urges Providers To Work With Registered Compounders
U.S. public health regulators have expanded oversight of drug compounders choosing to register with the U.S. Food and Drug Administration, but the agency will help boost participation despite its voluntary nature...To view the full article, register now.
Already a subscriber? Click here to view full article